Page 24 - The Indian Optician Digital Edition July-August 2021

ESSILORLUXOTTICA AND to bring the latest, evidence-

COACH RENEW PARTNERSHIP based information directly to
all ECPs across the world which
would not be possible without
our industry supporters.”

Oculus’s sponsorship of
the Australia-based Institute
comes at an exciting time
in myopia research. The IMI
recently published Volume
two of the 2021 white papers
and yearly digest in a special
issue of the peer-reviewed
Investigative Ophthalmology
and Visual Science (IOVS) and
EssilorLuxottica and Coach have renewed their license is now also releasing the IMI
agreement for the design, production and worldwide 2021 clinical summaries.
distribution of prescription frames and sunglasses globally
under the Coach Eyewear brand. The five-year agreement that Christian Kirchhübel, CEO of
came into effect on 1 July, 2021, is expected to run until 30 June, Oculus said: “We are delighted
2026 with the likelihood of an additional five-year extension. about the cooperation. Our
mission at Oculus is to support
“EssilorLuxottica is delighted to renew and further eye care professionals around
develop its partnership with Coach, a leading design brand the world with cutting-edge,
which represents authentic craftsmanship and luxury high-tech development. We
modern American style. Through our new branded eyewear love saving and improving
collections, we continue to build loyalty and strengthen our vision and are known for
emotional connection with Coach’s clients around the world,” our innovative and reliable
commented Francesco Milleri, CEO of EssilorLuxottica. measurement solutions.”
“We are so pleased to renew our successful partnership “There remains much to do
with Luxottica,” said Todd Kahn, CEO and Brand President of in terms of growing myopia
Coach. “We are excited for the next chapter of our relationship, awareness and improving both
and are looking forward to continuing to create beautiful eye care practitioner and the
eyewear that is crafted to last.” general public’s knowledge
of the need and ability to slow
OCULUS JOINS IMI TO SUPPORT myopia progression clinically,”
added IMI Chair, Professor
MYOPIA RESEARCH Serge Resnikoff. “We are

looking forward to continuing
to work with OCULUS and
German ophthalmic medical device manufacturer, Oculus, all our sponsors in making
has announced their support of the International Myopia Institute evidence-based knowledge
(IMI), activities to advance the research and awareness of myopia to on myopia treatment and
prevent future vision impairment and blindness. prevention freely available.”

Announcing this through a press release, IMI Executive Director, The latest IMI white papers
Dr Monica Jong, said, “We are thrilled to have Oculus join in our and clinical summaries in up
mission to advance research, patient management and education to twelve international
in myopia. Open collaboration and sharing of knowledge globally languages can be accessed
with eye care practitioners (ECPs) are critical to prevent future at myopiainstitute.org/imi-
myopia-related vision impairment and blindness. We will continue white-papers/.

| JULY-AUGUST 2021 | 20 INTERNATIONAL NEWS